Maruti, Honda, Mahindra and others stops manufacturing due to Covid19 outbreak

▴ Maruti Honda Mahindra and others stops manufacturing due to Covid19 outbreak
All automakers stops production til 31st March

Maruti Suzuki India (MSI), Mahindra & Mahindra and Honda Cars, recentlyannounced suspension of manufacturing activities across plants in the wake of the coronavirus outbreak in the country.

 MSI stopped production at its Gurgaon and Manesar plants with immediate effect, while Honda Cars India Ltd (HCIL) to end manufacturing at its two plants in the country till 31 March.

Meanwhile Mahindra & Mahindra (M&M) announced to suspend production at its manufacturing plants in Maharashtra.

Automaker Fiat also suspends  production in the country till the end of this month.

From other automobile companies,Hero MotoCorp and Honda Motorcycle and Scooter India (HMSI) suspended production across their manufacturing plants.

HMSI said, "The company will shut production and office operations at its facilities in Gurugram and Manesar (Haryana) with immediate effect till further notice."

The company's research and development centre at Rohtak will also remain closed, it added.

The duration of this shutdown will depend upon government policy, MSI said.

The company's two plants in Haryana—Manesar and Gurgaon—churn out 15.5 lakh vehicles per annum.

HCIL said production operations at  manufacturing plants in Greater Noida (Uttar Pradesh) and Tapukara (Rajasthan) will suspended from 23-31 March.

The company said its intention is to restart production on 1 April, however, this will be dependent upon advice from the government, health authorities, and market and supply conditions.

M&M said it has suspended manufacturing operations at its Nagpur plant with immediate effect and will also halt production at Chakan (Pune) and Kandivali (Mumbai) from Monday.

None of the company plants is working on Sunday also, M&M added.

"We are carefully monitoring the rapidly evolving COVID-19 pandemic and will continue to take swift and appropriate action on other plants in Maharashtra and across the nation," the company said.

Meanwhile, all company offices across the country have been ordered to work from home, it added.

Similarly, automaker Fiat Chrysler Automobiles (FCA) together with Fiat India Automobiles Private Limited (FIAPL), FCA's joint venture manufacturing facility in Ranjangaon, said the temporary suspension is in response to the increasing prevalence of positive COVID-19 cases in Maharashtra and particularly in Pune.

"There will be no retrenchment of any plant employees as a result of the plant closure and all will continue to receive their salaries during this closure period", the company said.

MG Motor India said production at its Halol (Gujarat) plant is closed till 25 March.

Market leader Hero MotoCorp said it has suspended production until 31 March.

"With the safety and well-being of its employees as top priority in view of the escalating COVID-19 situation, the company has decided to halt operations at all its global manufacturing facilities—including in India, Colombia and Bangladesh—and the Global Parts Centre (GPC) at Neemrana with immediate effect until 31 March, 2020," Hero MotoCorp said.

Employees at all the other functions and locations, including the Centre of Innovation and Technology (CIT) at Jaipur, will continue to work from home, except for those whose physical presence is necessary to run the day-to-day essential services, it added.

Similarly, Honda Motorcycle and Scooter India (HMSI) said it has suspended operations across its four manufacturing plants in the country with immediate effect.

"The well-being of employees and all stakeholders being the top priority, the company has temporarily announced shutdown of operations across all its four manufacturing plants with immediate effect till further notice," HMSI

Story Input :Firstpost

Tags : #Maruti #Honda #Mahinda #Fiat #Heromotocorp #Hmsi #MGmotor

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024